Dual Role for Plasminogen Activator Inhibitor Type 1 as Soluble and as Matricellular Regulator of Epithelial Alveolar Cell Wound Healing
- 30 November 2006
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 169 (5), 1624-1632
- https://doi.org/10.2353/ajpath.2006.051053
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cellsExperimental Cell Research, 2004
- Expression of urokinase‐type plasminogen activator and its receptor is up‐regulated during tendon healingJournal of Orthopaedic Research, 2003
- Matricellular proteins as modulators of wound healing and the foreign body responseThrombosis and Haemostasis, 2003
- Regulation of Rac1 activation by the low density lipoprotein receptor–related proteinThe Journal of cell biology, 2002
- Promigratory Effect of Plasminogen Activator Inhibitor-1 on Invasive Breast Cancer Cell PopulationsThe American Journal of Pathology, 2002
- Involvement of the [uPAR:uPA:PAI-1:LRP] Complex in Human Myogenic Cell MotilityExperimental Cell Research, 2000
- PAI-1 Gene Expression Is Growth State-Regulated in Cultured Human Epidermal Keratinocytes during Progression to Confluence and PostwoundingExperimental Cell Research, 1996
- Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats.JCI Insight, 1995
- Urokinase-Urokinase Receptor Interaction: Non-Mitogenic Signal Transduction in Human Epidermal CellsBiochemical and Biophysical Research Communications, 1993
- Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectinCell Differentiation and Development, 1990